PMCB

PMCB

USD

PharmaCyte Biotech Inc. Common Stock

$0.890-0.010 (-1.111%)

Цена в режиме реального времени

Healthcare
Биотехнология
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$0.900

Максимум

$0.917

Минимум

$0.880

Объем

0.00M

Фундаментальные показатели компании

Рыночная капитализация

6.0M

Отрасль

Биотехнология

Страна

United States

Статистические данные торговли

Средний объем

0.10M

Биржа

NCM

Валюта

USD

52-недельный диапазон

Минимум $0.8Текущая $0.890Максимум $1.94

Связанные новости

BusinessWire

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner's 2025 Hype Cycle for Data Center Infrastructure Technologies PharmaCyte Biotech, Inc. (NASDAQ:PMCB)

Просмотреть больше
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
BusinessWire

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company"), today announced the closing of its previously announced $7 million financing. As of April 30, 2025, PharmaCyte had approximately $15.5 million in

Просмотреть больше
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
BusinessWire

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announced today that it has entered into a securities purchase agreement for a $7.0 million financing with existing investors involving the sale of

Просмотреть больше
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.